These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 1449103)

  • 41. Pharmacologic treatment of angina: nitrate tolerance.
    Parker JO
    Hosp Pract (Off Ed); 1988 Nov; 23(11):63-71, 76-7, 80-3. PubMed ID: 2903167
    [No Abstract]   [Full Text] [Related]  

  • 42. A sustained release formulation of isosorbide-5-mononitrate with a rapid onset of action.
    Arthur RM; Mehmel H
    Int J Clin Pract; 1999; 53(3):205-12. PubMed ID: 10665134
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Isosorbide-5-mononitrate in angina pectoris: its efficacy and absence of tolerance and rebound with an eccentric type of administration].
    Schneeweiss A; Reisin L; Marmor A; Caspi A
    Cardiology; 1994; 84 Suppl 1():4-12. PubMed ID: 8087823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nitrate tolerance. A problem during continuous nitrate administration.
    Parker JO
    Eur J Clin Pharmacol; 1990; 38 Suppl 1():S21-5. PubMed ID: 2113001
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differences in ischemic threshold and nitrate efficacy between normotensive and hypertensive patients with stable angina pectoris.
    Marmor A; Reizin L; Caspi A; Botvin S; Schneeweiss A
    Hypertens Res; 1995 Jun; 18(2):119-24. PubMed ID: 7584917
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Randomized crossover trial of isosorbide mononitrate (Elantan 20) and slow-release glyceryl trinitrate in the treatment of angina pectoris.
    Brodie NH; O'Hara H; O'Hara J; Valle-Jones JC
    Pharmatherapeutica; 1985; 4(6):367-75. PubMed ID: 3936056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comments on 'A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily and isosorbide dinitrate twice daily in patients with stable angina'.
    Nyberg G
    Int J Cardiol; 1997 Jun; 60(1):107-10. PubMed ID: 9209948
    [No Abstract]   [Full Text] [Related]  

  • 48. Recent developments in the use of nitrates for treatment of angina pectoris.
    Ankier SI; Warrington SJ; Sneddon JM
    J Int Med Res; 1988; 16(4):249-56. PubMed ID: 3139481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate.
    Bharani A; Ganguli A; Mathur LK; Jamra Y; Raman PG
    Indian Heart J; 2002; 54(2):170-5. PubMed ID: 12086380
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nitrate tolerance.
    Parker JO
    Herz; 1984 Jun; 9(3):137-45. PubMed ID: 6430767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of multiple-dose and once-daily nitrate therapy in 1212 patients with stable angina pectoris: effects on quality of life indices. Dutch Mononitrate Quality of Life (DUMQOL) Study Group.
    Niemeyer MG; Kleinjans HA; de Ree R; Zwinderman AH; Cleophas TJ; van der Wall EE
    Angiology; 1997 Oct; 48(10):855-62. PubMed ID: 9342964
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics of isosorbide mononitrate.
    Abshagen UW
    Am J Cardiol; 1992 Nov; 70(17):61G-66G. PubMed ID: 1449102
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
    Thadani U
    Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of once daily versus twice daily oral nitrates in stable angina pectoris.
    Kardas P;
    Am J Cardiol; 2004 Jul; 94(2):213-6. PubMed ID: 15246905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical pharmacokinetics of nitrates.
    Bogaert MG
    Cardiovasc Drugs Ther; 1994 Oct; 8(5):693-9. PubMed ID: 7873466
    [TBL] [Abstract][Full Text] [Related]  

  • 56. What intervals in oral therapy of isosorbide dinitrate in various doses are sufficient to prevent nitrate tolerance?
    Kośmicki M; Sadowski Z; Szwed H; Kowalik I
    Med Sci Monit; 2000; 6(4):763-8. PubMed ID: 11208406
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
    Döring G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An open, long-term, multi-centre study of the anti-anginal efficacy and safety of isosorbide 5-mononitrate at low doses in patients with coronary heart disease.
    Uberbacher HJ; Steinorth G; Glocke M; Abshagen U
    Pharmatherapeutica; 1983; 3(5):331-41. PubMed ID: 6342004
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of controlled-release isosorbide-5-mononitrate in Japanese patients with stable effort angina pectoris.
    Shimada K; Sunayama S; Nakazato K; Satoh H; Kusama Y; Kawakubo K; Daida H
    Int Heart J; 2006 Sep; 47(5):695-705. PubMed ID: 17106140
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sustained-release isosorbide mononitrate (50 mg): optimization of a once-daily dosage form for long-term treatment of angina pectoris.
    Bonn R
    Am J Cardiol; 1988 Mar; 61(9):12E-14E. PubMed ID: 3348135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.